BlackRock Fund Advisors’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $17.7M | Buy |
1,703,987
+196,749
| +13% | +$2.05M | ﹤0.01% | 2252 |
|
|
2016
Q3 | $13.6M | Buy |
1,507,238
+98,740
| +7% | +$894K | ﹤0.01% | 2279 |
|
|
2016
Q2 | $10.5M | Buy |
1,408,498
+107,049
| +8% | +$801K | ﹤0.01% | 2383 |
|
|
2016
Q1 | $11.7M | Buy |
1,301,449
+275,914
| +27% | +$2.49M | ﹤0.01% | 2273 |
|
|
2015
Q4 | $13.3M | Buy |
1,025,535
+4,391
| +0.4% | +$56.7K | ﹤0.01% | 2288 |
|
|
2015
Q3 | $9.86M | Buy |
1,021,144
+31,621
| +3% | +$305K | ﹤0.01% | 2376 |
|
|
2015
Q2 | $10.2M | Buy |
989,523
+515,500
| +109% | +$5.3M | ﹤0.01% | 2486 |
|
|
2015
Q1 | $5.27M | Buy |
474,023
+16,739
| +4% | +$186K | ﹤0.01% | 2817 |
|
|
2014
Q4 | $5.32M | Buy |
457,284
+268,909
| +143% | +$3.13M | ﹤0.01% | 2841 |
|
|
2014
Q3 | $4.17M | Sell |
188,375
-4,442
| -2% | -$98.3K | ﹤0.01% | 2857 |
|
|
2014
Q2 | $5.36M | Buy |
+192,817
| New | +$5.36M | ﹤0.01% | 2793 |
|